Local firms eye slice of Sh81b pharma industry

Audio By Vocalize

By 2030, it is estimated that local pharmaceutical firms would have invested up to Sh23.2 billion ($200 million) in human resources and infrastructure to match international standards.

Investments in these areas have been necessitated by the existing gaps in the country and the continent at large in the sector which is behind Kenya importing 70 per cent of pharmaceuticals. This has made Kenya lag behind in meeting the global manufacturing standards for pharmaceuticals - a challenge Nihal Shah, chief executive officer Biodeal Laboratories Ltd says manufacturers in the sector seek to address.